Overview

3 Month Outcome of Ziv-aflibercept for DME

Status:
Completed
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
The purpose is to show the 3-month efficacy and safety in diabetic macular edema treated with intravitreal ziv-aflibercept.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Marashi Eye Clinic
Treatments:
Aflibercept